Global Genetic Disease Diagnosis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 102 pages | ID: G99A9BB9A55DEN
GlobalInfoResearch

Abstracts

The Genetic Disease Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Genetic Disease Diagnosis market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation

Genetic Disease Diagnosis market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Robotic Radiosurgery
• Usage Of Molecular Target Agents
• Others

Market segment by Application, can be divided into

• Inherited Disorder Testing
• Pharmacogenetic Testing (PGx)
• Human Leukocyte Antigen (HLA) Testing
• Oncology Testing
• Others

Market segment by players, this report covers

• Abbott Laboratories
• Siemens Healthineers
• Roche Diagnostics Corp
• Bayer Diagnostics
• Sysmex Corporation
• Cephide
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Illumina, Inc
• Applied Biosystems
• Transgenomic Inc
• AutoGenomics

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Genetic Disease Diagnosis product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Genetic Disease Diagnosis, with recent developments and future plans

Chapter 3, the Genetic Disease Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Genetic Disease Diagnosis market forecast, by regions, with revenue, from 2023 to 2029.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.

Chapter 7 and 8, to describe Genetic Disease Diagnosis research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Genetic Disease Diagnosis
1.2 Classification of Genetic Disease Diagnosis by Type
  1.2.1 Overview: Global Genetic Disease Diagnosis Market Size by Type: 2022 Versus 2028
  1.2.2 Global Genetic Disease Diagnosis Revenue Market Share by Type in 2029
  1.2.3 Robotic Radiosurgery
  1.2.4 Usage Of Molecular Target Agents
  1.2.5 Others
1.3 Global Genetic Disease Diagnosis Market by Application
  1.3.1 Overview: Global Genetic Disease Diagnosis Market Size by Application: 2023 Versus 2029
  1.3.2 Inherited Disorder Testing
  1.3.3 Pharmacogenetic Testing (PGx)
  1.3.4 Human Leukocyte Antigen (HLA) Testing
  1.3.5 Oncology Testing
  1.3.6 Others
1.4 Global Genetic Disease Diagnosis Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Genetic Disease Diagnosis Market Drivers
  1.5.2 Genetic Disease Diagnosis Market Restraints
  1.5.3 Genetic Disease Diagnosis Trends Analysis

2 COMPANY PROFILES

2.1 Abbott Laboratories
  2.1.1 Abbott Laboratories Details
  2.1.2 Abbott Laboratories Major Business
  2.1.3 Abbott Laboratories Genetic Disease Diagnosis Product and Solutions
  2.1.4 Abbott Laboratories Recent Developments and Future Plans
2.2 Siemens Healthineers
  2.2.1 Siemens Healthineers Details
  2.2.2 Siemens Healthineers Major Business
  2.2.3 Siemens Healthineers Genetic Disease Diagnosis Product and Solutions
  2.2.4 Siemens Healthineers Recent Developments and Future Plans
2.3 Roche Diagnostics Corp
  2.3.1 Roche Diagnostics Corp Details
  2.3.2 Roche Diagnostics Corp Major Business
  2.3.3 Roche Diagnostics Corp Genetic Disease Diagnosis Product and Solutions
  2.3.4 Roche Diagnostics Corp Recent Developments and Future Plans
2.4 Bayer Diagnostics
  2.4.1 Bayer Diagnostics Details
  2.4.2 Bayer Diagnostics Major Business
  2.4.3 Bayer Diagnostics Genetic Disease Diagnosis Product and Solutions
  2.4.4 Bayer Diagnostics Recent Developments and Future Plans
2.5 Sysmex Corporation
  2.5.1 Sysmex Corporation Details
  2.5.2 Sysmex Corporation Major Business
  2.5.3 Sysmex Corporation Genetic Disease Diagnosis Product and Solutions
  2.5.4 Sysmex Corporation Recent Developments and Future Plans
2.6 Cephide
  2.6.1 Cephide Details
  2.6.2 Cephide Major Business
  2.6.3 Cephide Genetic Disease Diagnosis Product and Solutions
  2.6.4 Cephide Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
  2.7.1 Bio-Rad Laboratories Details
  2.7.2 Bio-Rad Laboratories Major Business
  2.7.3 Bio-Rad Laboratories Genetic Disease Diagnosis Product and Solutions
  2.7.4 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
  2.8.1 Thermo Fisher Scientific Details
  2.8.2 Thermo Fisher Scientific Major Business
  2.8.3 Thermo Fisher Scientific Genetic Disease Diagnosis Product and Solutions
  2.8.4 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Illumina, Inc
  2.9.1 Illumina, Inc Details
  2.9.2 Illumina, Inc Major Business
  2.9.3 Illumina, Inc Genetic Disease Diagnosis Product and Solutions
  2.9.4 Illumina, Inc Recent Developments and Future Plans
2.10 Applied Biosystems
  2.10.1 Applied Biosystems Details
  2.10.2 Applied Biosystems Major Business
  2.10.3 Applied Biosystems Genetic Disease Diagnosis Product and Solutions
  2.10.4 Applied Biosystems Recent Developments and Future Plans
2.11 Transgenomic Inc
  2.11.1 Transgenomic Inc Details
  2.11.2 Transgenomic Inc Major Business
  2.11.3 Transgenomic Inc Genetic Disease Diagnosis Product and Solutions
  2.11.4 Transgenomic Inc Recent Developments and Future Plans
2.12 AutoGenomics
  2.12.1 AutoGenomics Details
  2.12.2 AutoGenomics Major Business
  2.12.3 AutoGenomics Genetic Disease Diagnosis Product and Solutions
  2.12.4 AutoGenomics Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Genetic Disease Diagnosis Revenue and Share by Players (2023 & 2029)
3.2 Genetic Disease Diagnosis Players Head Office, Products and Services Provided
3.3 Genetic Disease Diagnosis Mergers & Acquisitions
3.4 Genetic Disease Diagnosis New Entrants and Expansion Plans

4 GLOBAL GENETIC DISEASE DIAGNOSIS FORECAST BY REGION

4.1 Global Genetic Disease Diagnosis Market Size by Region: 2023 VS 2029
4.2 Global Genetic Disease Diagnosis Market Size by Region, (2023-2029)
4.3 North America
  4.3.1 Key Companies of Genetic Disease Diagnosis in North America
  4.3.2 Current Situation and Forecast of Genetic Disease Diagnosis in North America
  4.3.3 North America Genetic Disease Diagnosis Market Size and Prospect (2023-2029)
4.4 Europe
  4.4.1 Key Companies of Genetic Disease Diagnosis in Europe
  4.4.2 Current Situation and Forecast of Genetic Disease Diagnosis in Europe
  4.4.3 Europe Genetic Disease Diagnosis Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
  4.5.1 Key Companies of Genetic Disease Diagnosis in Asia-Pacific
  4.5.2 Current Situation and Forecast of Genetic Disease Diagnosis in Asia-Pacific
  4.5.3 Asia-Pacific Genetic Disease Diagnosis Market Size and Prospect (2023-2029)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Genetic Disease Diagnosis in South America
  4.6.2 Current Situation and Forecast of Genetic Disease Diagnosis in South America
  4.6.3 South America Genetic Disease Diagnosis Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
  4.7.1 Key Companies of Genetic Disease Diagnosis in Middle East & Africa
  4.7.2 Current Situation and Forecast of Genetic Disease Diagnosis in Middle East & Africa
  4.7.3 Middle East & Africa Genetic Disease Diagnosis Market Size and Prospect (2023-2029)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Genetic Disease Diagnosis Market Forecast by Type (2023-2029)
5.2 Global Genetic Disease Diagnosis Market Share Forecast by Type (2023-2029)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Genetic Disease Diagnosis Market Forecast by Application (2023-2029)
6.2 Global Genetic Disease Diagnosis Market Share Forecast by Application (2023-2029)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Genetic Disease Diagnosis Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Genetic Disease Diagnosis Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Genetic Disease Diagnosis Product and Solutions
Table 6. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 7. Siemens Healthineers Major Business
Table 8. Siemens Healthineers Genetic Disease Diagnosis Product and Solutions
Table 9. Roche Diagnostics Corp Corporate Information, Head Office, and Major Competitors
Table 10. Roche Diagnostics Corp Major Business
Table 11. Roche Diagnostics Corp Genetic Disease Diagnosis Product and Solutions
Table 12. Bayer Diagnostics Corporate Information, Head Office, and Major Competitors
Table 13. Bayer Diagnostics Major Business
Table 14. Bayer Diagnostics Genetic Disease Diagnosis Product and Solutions
Table 15. Sysmex Corporation Corporate Information, Head Office, and Major Competitors
Table 16. Sysmex Corporation Major Business
Table 17. Sysmex Corporation Genetic Disease Diagnosis Product and Solutions
Table 18. Cephide Corporate Information, Head Office, and Major Competitors
Table 19. Cephide Major Business
Table 20. Cephide Genetic Disease Diagnosis Product and Solutions
Table 21. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 22. Bio-Rad Laboratories Major Business
Table 23. Bio-Rad Laboratories Genetic Disease Diagnosis Product and Solutions
Table 24. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 25. Thermo Fisher Scientific Major Business
Table 26. Thermo Fisher Scientific Genetic Disease Diagnosis Product and Solutions
Table 27. Illumina, Inc Corporate Information, Head Office, and Major Competitors
Table 28. Illumina, Inc Major Business
Table 29. Illumina, Inc Genetic Disease Diagnosis Product and Solutions
Table 30. Applied Biosystems Corporate Information, Head Office, and Major Competitors
Table 31. Applied Biosystems Major Business
Table 32. Applied Biosystems Genetic Disease Diagnosis Product and Solutions
Table 33. Transgenomic Inc Corporate Information, Head Office, and Major Competitors
Table 34. Transgenomic Inc Major Business
Table 35. Transgenomic Inc Genetic Disease Diagnosis Product and Solutions
Table 36. AutoGenomics Corporate Information, Head Office, and Major Competitors
Table 37. AutoGenomics Major Business
Table 38. AutoGenomics Genetic Disease Diagnosis Product and Solutions
Table 39. Global Genetic Disease Diagnosis Revenue (USD Million) by Players (2023 & 2029)
Table 40. Global Genetic Disease Diagnosis Revenue Share by Players (2023 & 2029)
Table 41. Genetic Disease Diagnosis Players Head Office, Products and Services Provided
Table 42. Genetic Disease Diagnosis Mergers & Acquisitions in the Past Five Years
Table 43. Genetic Disease Diagnosis New Entrants and Expansion Plans
Table 44. Global Market Genetic Disease Diagnosis Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 45. Global Genetic Disease Diagnosis Revenue Market Share by Region (2023-2029)
Table 46. Key Companies of Genetic Disease Diagnosis in North America
Table 47. Current Situation and Forecast of Genetic Disease Diagnosis in North America
Table 48. Key Companies of Genetic Disease Diagnosis in Europe
Table 49. Current Situation and Forecast of Genetic Disease Diagnosis in Europe
Table 50. Key Companies of Genetic Disease Diagnosis in Asia-Pacific
Table 51. Current Situation and Forecast of Genetic Disease Diagnosis in Asia-Pacific
Table 52. Key Companies of Genetic Disease Diagnosis in China
Table 53. Key Companies of Genetic Disease Diagnosis in Japan
Table 54. Key Companies of Genetic Disease Diagnosis in South Korea
Table 55. Key Companies of Genetic Disease Diagnosis in South America
Table 56. Current Situation and Forecast of Genetic Disease Diagnosis in South America
Table 57. Key Companies of Genetic Disease Diagnosis in Middle East & Africa
Table 58. Current Situation and Forecast of Genetic Disease Diagnosis in Middle East & Africa
Table 59. Global Genetic Disease Diagnosis Revenue Forecast by Type (2023-2029)
Table 60. Global Genetic Disease Diagnosis Revenue Forecast by Application (2023-2029)

List Of Figures

LIST OF FIGURES

Figure 1. Genetic Disease Diagnosis Picture
Figure 2. Global Genetic Disease Diagnosis Revenue Market Share by Type in 2029
Figure 3. Robotic Radiosurgery
Figure 4. Usage Of Molecular Target Agents
Figure 5. Others
Figure 6. Genetic Disease Diagnosis Revenue Market Share by Application in 2029
Figure 7. Inherited Disorder Testing Picture
Figure 8. Pharmacogenetic Testing (PGx) Picture
Figure 9. Human Leukocyte Antigen (HLA) Testing Picture
Figure 10. Oncology Testing Picture
Figure 11. Others Picture
Figure 12. Global Genetic Disease Diagnosis Market Size, (USD Million): 2023 VS 2029
Figure 13. Global Genetic Disease Diagnosis Revenue and Forecast (2023-2029) & (USD Million)
Figure 14. Genetic Disease Diagnosis Market Drivers
Figure 15. Genetic Disease Diagnosis Market Restraints
Figure 16. Genetic Disease Diagnosis Market Trends
Figure 17. Abbott Laboratories Recent Developments and Future Plans
Figure 18. Siemens Healthineers Recent Developments and Future Plans
Figure 19. Roche Diagnostics Corp Recent Developments and Future Plans
Figure 20. Bayer Diagnostics Recent Developments and Future Plans
Figure 21. Sysmex Corporation Recent Developments and Future Plans
Figure 22. Cephide Recent Developments and Future Plans
Figure 23. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Illumina, Inc Recent Developments and Future Plans
Figure 26. Applied Biosystems Recent Developments and Future Plans
Figure 27. Transgenomic Inc Recent Developments and Future Plans
Figure 28. AutoGenomics Recent Developments and Future Plans
Figure 29. Global Genetic Disease Diagnosis Revenue Market Share by Region (2023-2029)
Figure 30. Global Genetic Disease Diagnosis Revenue Market Share by Region in 2029
Figure 31. North America Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)
Figure 32. Europe Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)
Figure 33. Asia-Pacific Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)
Figure 34. South America Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)
Figure 35. Middle East & Africa Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)
Figure 36. Global Genetic Disease Diagnosis Market Share Forecast by Type (2023-2029)
Figure 37. Global Genetic Disease Diagnosis Market Share Forecast by Application (2023-2029)
Figure 38. Methodology
Figure 39. Research Process and Data Source